"Bayhealth is southern and central Delaware's healthcare leader. We are here to strengthen the health of our community one life at a time."

During the past decade, Bayhealth Hospital Sussex Campus conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bayhealth Hospital Sussex Campus" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "NRG Oncology" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bayhealth Hospital Sussex Campus" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Bayhealth Hospital Sussex Campus" are "Stage IV Lung Cancer AJCC v8" (6 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials), "Stage IVB Lung Cancer AJCC v8" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials) and "Stage III Lung Cancer AJCC v8" (3 trials). Many other conditions were trialed in "Bayhealth Hospital Sussex Campus" in a lesser frequency.

Most popular intervention types in "Bayhealth Hospital Sussex Campus" are "Drug" (15 trials), "Other" (7 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Laboratory Biomarker Analysis" (3 trials), "Cisplatin" (2 trials), "Docetaxel" (2 trials) and "Etoposide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bayhealth Hospital Sussex Campus" are 13 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Bayhealth Hospital Sussex Campus". undefined are not yet recruiting, 5 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Bayhealth Hospital Sussex Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bayhealth Hospital Sussex Campus, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".